A protective role for IL‐6 during early infection with Toxoplasma gondii
- 1 May 1998
- journal article
- research article
- Published by Wiley in Parasite Immunology
- Vol. 20 (5), 231-239
- https://doi.org/10.1046/j.1365-3024.1998.00152.x
Abstract
IL‐6 deficient mice were found to be signifcantly more susceptible to peroral infection with Toxoplasma gondii than their wild‐type counterparts as measured by survival, brain cyst burdens and brain pathology at 28 days post‐infection. The physical manifestations of disease, such as weight loss, were not observed in IL‐6 deficient animals until at least seven days later than such changes occurred in wild‐type mice. During this early stage of infection IL‐6+/+ but not IL‐6−/− mice mounted a peripheral blood neutrophilia. Furthermore, between 6–8 days post‐infection there was a significant increase in plasma IFN‐γ levels in wild‐type but not IL‐6 deficient mice. Not until days 18–23 post‐infection, concurrent with the majority of deaths in IL‐6−/− mice, were plasma IFN‐γ levels substantially and significantly raised in IL‐6−/− mice. At this time not only were these plasma IFN‐γ levels 20‐fold higher than background but eight‐fold greater than peak (6–8 days post‐infection) IFN‐γ levels in IL‐6+/+ mice. IFN‐γ dependent parasite specific IgG2a levels were also significantly higher in IL‐6−/− mice over this period and thereafter. Overall the evidence suggests that in the absence of IL‐6 mice are unable to initiate a rapid proinflammatory response against T. gondii, which allows increased parasite growth. Increased mortality in IL‐6−/− mice may be directly due to this increased parasite burden and the excessive inflammatory response this induces three weeks post‐infection.Keywords
This publication has 58 references indexed in Scilit:
- IL-12: a key cytokine in immune regulationImmunology Today, 1996
- Impaired neutrophil response and CD4+ T helper cell 1 development in interleukin 6-deficient mice infected with Candida albicans.The Journal of Experimental Medicine, 1996
- Transforming growth factor‐β inhibits interleukin‐12‐induced production of interferon‐γ by natural killer cells: A role for transforming growth factor‐β in the regulation of T cell‐independent resistance to Toxoplasma gondiiEuropean Journal of Immunology, 1995
- Impaired immune and acute-phase responses in interleukin-6-deficient miceNature, 1994
- Interleukin 10: An overviewProgress in Growth Factor Research, 1992
- Protective effect of anti‐interleukin (IL)‐6 antibody against endotoxin, associated with paradoxically increased IL‐6 levelsEuropean Journal of Immunology, 1992
- Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection.The Journal of Experimental Medicine, 1992
- Activation of neutrophils by recombinant interleukin 6Cellular Immunology, 1989
- Activity of Human Blood Leukocytes against Toxoplasma gondiiThe Journal of Infectious Diseases, 1979
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976